Literature DB >> 7779703

The effect of dose and interval between 5-fluorouracil and leucovorin on the formation of thymidylate synthase ternary complex in human cancer cells.

J C Drake1, D M Voeller, C J Allegra, P G Johnston.   

Abstract

We examined the importance of dosing interval between leucovorin (LCV) and 5-fluorouracil (5-FU) on intracellular thymidylate synthase (TS) ternary complex, free TS and total TS protein levels in human MCF-7 breast and NCI H630 colon cancer cell lines. A 2- to 3-fold increase in total TS was noted when either cell line was exposed to 5-FU 10 microM plus LCV (0.01-10 microM) compared with a 1.4- to 1.6-fold increase in total TS due to 5-FU 10 microM alone. The amount of TS ternary complex formed was 2- to 3-fold higher in both cell lines treated with the combination of 5-FU and LCV compared with 5-FU alone. TS complex formation and total TS protein increased with LCV dose (0.1-10 microM). In MCF-7 cells, the maximal increase in total TS protein and TS ternary complex formation was observed when 5-FU was delayed for 4 h after the start of LCV exposure. In NCI H630 cells, maximal total TS protein and ternary complex formation occurred when 5-FU was delayed for 18 h after the start of LCV exposure. The amount of free TS did not change in either cell line whether 5-FU was given concurrently with LCV or delayed for up to 24 h. The accumulation rate of intracellular folates in the form of higher glutamates Glu3-Glu5 was rapid in MCF-7 cells (maximal formation after 4 h), whereas in H630 cells accumulation of higher polyglutamates continued to increase up to 18 h. The time of peak folate polyglutamate (Glu3-Glu5) formation coincided with the time of peak TS complex formation and total TS protein in each cell line. In these human carcinoma cell lines, the LCV dose and interval between 5-FU and LCV play a role in increased TS total protein and TS ternary complex; however, the amount of free TS is independent of the interval between 5-FU and LCV. The time-and dose-dependent increases in TS ternary complex and TS total protein are associated with differences in the accumulation of folate polyglutamates in these cell lines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7779703      PMCID: PMC2033846          DOI: 10.1038/bjc.1995.224

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  31 in total

Review 1.  Thymidylate synthetase - a target enzyme in cancer chemotherapy.

Authors:  P V Danenberg
Journal:  Biochim Biophys Acta       Date:  1977-12-23

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

Review 3.  Chemotherapy of gastrointestinal cancer.

Authors:  C G Moertel
Journal:  N Engl J Med       Date:  1978-11-09       Impact factor: 91.245

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate.

Authors:  D V Santi; C S McHenry; H Sommer
Journal:  Biochemistry       Date:  1974-01-29       Impact factor: 3.162

6.  Thymidylate synthetase and 2'-deoxyuridylate form a tight complex in the presence of pteroyltriglutamate.

Authors:  A Lockshin; P V Danenberg
Journal:  J Biol Chem       Date:  1979-12-25       Impact factor: 5.157

7.  Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice.

Authors:  J A Houghton; S J Maroda; J O Phillips; P J Houghton
Journal:  Cancer Res       Date:  1981-01       Impact factor: 12.701

8.  Cytotoxicity of 5-fluoro-2'-deoxyuridine: requirement for reduced folate cofactors and antagonism by methotrexate.

Authors:  B Ullman; M Lee; D W Martin; D V Santi
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

9.  Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil.

Authors:  C P Spears; B G Gustavsson; M S Mitchell; D Spicer; M Berne; L Bernstein; P V Danenberg
Journal:  Cancer Res       Date:  1984-09       Impact factor: 12.701

10.  Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human colorectal carcinoma cell lines.

Authors:  J G Park; J M Collins; A F Gazdar; C J Allegra; S M Steinberg; R F Greene; B S Kramer
Journal:  J Natl Cancer Inst       Date:  1988-12-07       Impact factor: 13.506

View more
  4 in total

Review 1.  Targeting nuclear thymidylate biosynthesis.

Authors:  James Chon; Patrick J Stover; Martha S Field
Journal:  Mol Aspects Med       Date:  2016-11-19

2.  Does leucovorin alter the intratumoral pharmacokinetics of 5-fluorouracil (5-FU)? A Southwest Oncology Group study.

Authors:  Cary A Presant; Joth Jacobson; Walter Wolf; Victor Waluch; Ilene C Weitz; John S Macdonald
Journal:  Invest New Drugs       Date:  2002-11       Impact factor: 3.850

3.  Influence of thymidylate synthase and p53 protein expression on clinical outcome in patients with colorectal cancer.

Authors:  R Broll; P Busch; M Duchrow; E Oevermann; O Schwandner; S Farke; H P Bruch; U Windhövel
Journal:  Int J Colorectal Dis       Date:  2004-08-10       Impact factor: 2.571

4.  Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase.

Authors:  Ayako Nakamura; Go Nakajima; Ryuji Okuyama; Hidekazu Kuramochi; Yurin Kondoh; Toshinori Kanemura; Teiji Takechi; Masakazu Yamamoto; Kazuhiko Hayashi
Journal:  Gastric Cancer       Date:  2013-03-15       Impact factor: 7.370

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.